Who are Neumora Therapeutics, Inc.'s main suppliers?

Neumora Therapeutics, Inc. (NMRA) key suppliers include: Amgen Inc., Amgen Inc., VANDERBILT, TSRI. View the full supplier network at chainsifter.com/chain/NMRA.

Who are Neumora Therapeutics, Inc.'s major customers?

Neumora Therapeutics, Inc. (NMRA) key customers include: Xenon Pharmaceuticals Inc.. View the full customer network at chainsifter.com/chain/NMRA.

What sector is Neumora Therapeutics, Inc. in?

Neumora Therapeutics, Inc. (NMRA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

NMRA Supply Chain: Neumora Therapeutics, Inc. Supplier List & 8 Relationships

4Suppliers

1Customers

3Debt Items

20Related Chains

Neumora Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
AMGN	Amgen Inc.	90%	Additionally, Amgen purchased 12.7 million shares of our Series A-2 Preferred Stock at a purchase price of $7.85 per share, for total consideration of $100.0 million.
AMGN	Amgen Inc.	90%	Reciprocal relationship from AMGN graph: Reciprocal relationship from NMRA graph: Additionally, Amgen purchased 12.7 million shares of our Series A-2 Preferred Stock at a purchase price of $7.85 per …
VANDERBILT	VANDERBILT	90%	In November 2023 and July 2025, a $2.0 and $5.0 million, respectively, development milestone was paid to Vanderbilt under the Vanderbilt License Agreement.
TSRI	TSRI	80%	Pursuant to the 2015 TSRI License Agreement, TSRI granted us a worldwide, exclusive license under certain patent rights and a worldwide, non-exclusive license under certain know-how relating to TSRI'…

Neumora Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
XENE	Xenon Pharmaceuticals Inc.	72%	Reciprocal relationship from XENE graph: velopment and marketing efforts of our collaborators. • Our reliance on third parties to manufacture our product candidates may increase the risk that we will…

Neumora Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
NMRA-DEBT-11312	Warrants outstanding: 1613000	90%	xbrl warrant detail from xbrl 2022-12-31.
NMRA-DEBT	Debt stack $55.0M	90%	Market cache reports total debt of $55.0M.
NMRA-DEBT-20260	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.

Neumora Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Neumora Therapeutics, Inc..

Neumora Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
NMRA-OWNER-PERCEPTIVE-ADVISORS-LLC	PERCEPTIVE ADVISORS LLC	90%	13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 117 tracked holders.

Neumora Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
XENE	Xenon Pharmaceuticals Inc.	100.00	1	['customer']
AMGN	Amgen Inc.	100.00	1	['supplier']
EH	EHang Holdings Limited	100.00	2
ABT	Abbott Laboratories	100.00	2
BMY	Bristol-Myers Squibb Company	100.00	2
BMYMP	Bristol-Myers Squibb Co	100.00	2
EM	Smart Share Global Limited	100.00	2
NBIX	Neurocrine Biosciences, Inc.	100.00	2
PRE	Prenetics Global Limited	100.00	2
SNYNF	Sanofi	100.00	2
SBMFF	Sino Biopharmaceutical Limited	100.00	2
JNJ	Johnson & Johnson	100.00	2
LBRX	LB Pharmaceuticals Inc	100.00	2
NAUT	Nautilus Biotechnology, Inc.	50.00	2
HBIO	Harvard Bioscience, Inc.	50.00	2
RAPP	Rapport Therapeutics, Inc.	50.00	2
CTMX	CytomX Therapeutics, Inc.	50.00	2
PODD	Insulet Corporation	50.00	2
CUZ	Cousins Properties Incorporated	50.00	2
PRAX	Praxis Precision Medicines, Inc.	50.00	2

Neumora Therapeutics, Inc. Supply Chain